Evoke Pharma, Inc. Aktie News

William Hill owner Evoke PLC (LSE:EVOK) posted an update revealing that the past quarter was its strongest of the year, driven by gaming growth across all divisions. The bookmaker, which put itself up for sale last month after a rise in gambling taxes in the Budget, reported revenues of roughly £464 million for the fourth quarter, up 7% compared with the previous quarter but down 3% year-on-year.

Deutsche Bank has downgraded Evoke PLC (LSE:EVOK) and Rank Group PLC (LSE:RNK) to 'hold' from 'buy', slashing price targets as it reassessed the European gaming sector ahead of 2026. Evoke saw the sharpest cut.

Evoke Stockholders Received $11.00 Per Share in Cash SOLANA BEACH, Calif., and VERO BEACH, Fla.

Shares in William Hill owner Evoke PLC (LSE:EVOK) bounced 8% to 23.83p after the bookmaker confirmed that it is putting all or part of the company up for sale. A strategic review has been launched, the company said in a short statement, including "a range of potential alternatives to maximise shareholder value, including, but not limited to a potential sale of the group, or some of the company'...

Bookmakers Entain PLC (LSE:ENT), Evoke PLC (LSE:EVOK) and Flutter Entertainment PLC (LSE:FLTR, NYSE:FLUT) have warned investors of "highly damaging" consequences from the new UK gambling tax measures in yesterday's Budget, which are set to come into force from next April. Under changes announced in the autumn Budget, online gaming duty will rise to 40% from April 2026, and a new 25% remote bett...

British bookmaker Evoke has appointed bankers to assess options for the potential sale of its Italian online business if the government imposes steep tax increases in the upcoming budget, Sky News reported on Tuesday.

MILWAUKEE , Nov. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating Evoke (NASDAQ: EVOK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Evoke Pharma, Inc. (NASDAQ: EVOK) to QOL Medical, LLC for $11.00 per share in cash is fair to Evoke shareholders. Halper Sadeh encourages Evoke shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or s...